secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lyell Immunopharma, Inc. (LYEL)
CIK:        0001806952
Form:       8-K
Filed at:   2021-09-30T23:59:59+00:00
Accession:  0001193125-21-287960
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lyell Immunopharma Chair Dr. Richard Klausner takes medical leave; Friedman named interim Chair
--------------------------------------------------------------------------------

- Dr. Richard Klausner takes temporary medical leave; expected return early 2022. Resigns as Executive Chairman effective Oct 1, 2022 but remains Chair.
- Cathy Friedman, lead independent director, appointed interim Chair of Board during Klausner's absence.
- Company states leave will not impact IND timelines (four submissions by end 2022) or corporate objectives.
- Klausner issued a letter expressing confidence in management and team to continue mission during his leave.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1806952/000119312521287960/0001193125-21-287960-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1806952/000119312521287960/d237206d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-287960

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer